Pissa, M. et al. 2021. CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015–2020: implications for novel national recommendations. Acta Oncologica. 60, 7 (Jul. 2021), 888–896. DOI:https://doi.org/10.1080/0284186X.2021.1914346.